Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients
NCT03817554Phase 4Terminated
- Start
- Jul 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pramipexole in restless legs syndrome (RLS) (2 arms). Primary endpoint: International Restless Legs Syndrome Study Group Rating Scale at 12 weeks. Started Jul 2019; status: terminated.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03817554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03817554.